CASI PHARMACEUTICALS, INC. Total Liabilities
CASI PHARMACEUTICALS, INC. had Total Liabilities of $29.30 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-04-26
- 2022-12-31: Liabilities $29.30M.
- 2022-09-30: Liabilities $44.69M.
- 2022-06-30: Liabilities $29.25M.
- 2022-03-31: Liabilities $30.85M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2022-12-31 | $29.30M 20-F · filed 2023-04-26 | |
| 2022-09-30 | $44.69M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $29.25M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $30.85M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $30.34M 20-F · filed 2023-04-26 | |
| 2021-09-30 | $26.76M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $27.03M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $25.90M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $24.16M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $21.44M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $7.16M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $8.24M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.97M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $8.24M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.82M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.85M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.95M 10-K · filed 2020-03-16 | $3.95M 10-K · filed 2019-03-29 |
| 2018-09-30 | $6.99M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.19M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.54M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $6.56M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $7.14M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $7.11M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $6.94M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $6.93M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $8.73M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.94M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $9.89M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $11.91M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $11.83M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $12.03M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $12.01M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $11.73M 10-K · filed 2016-03-28 | |
| 2014-09-30 | $11.57M 10-Q · filed 2014-11-14 | |
| 2013-12-31 | $565.17K 10-K · filed 2015-03-27 |